ROIV roivant.com: Accounting Value per Share

Graphic logo of Roivant Sciences Ltd. (ROIV)

Roivant Sciences Ltd. is developing a biopharma holding company, monetizing promising developments through M&A. Its decentralized structure grants scientists autonomy in project management. The implementation of the VantAI AI platform automates molecule synthesis. The BVPS trend helps assess net assets, while the value of 5.84 captures the metric level. This allows for the analysis of the company's financial stability and capital efficiency.

Roivant (ROIV): Share Book Value from 07/04/2022 to 10/29/2026

roivant.com - analytical breakdowns and key metrics (ROIV)

- price and consensus price forecast:
Stock Price Roivant Sciences Ltd|ROIV - Analyst Median Target
- market capitalization data:
Market Valuation Roivant|ROIV - Total Company Value
- book capitalization data:
Net Assets per Single Share Roivant Sciences|ROIV - Net Asset Value|Market Capitalization to Book Value Ratio roivant.com|ROIV - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Roivant Sciences Ltd.|ROIV - Long-Term Debt to Capital|Short-Term Debt to Equity Roivant Sciences|ROIV - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Roivant|ROIV - Company Long-Term Liabilities|Company Short-Term Debts Roivant Sciences
Fundamental company valuation:Roivant Sciences Ltd - ROIV
Manufactured products of Roivant Sciences

Book value per share reflects the portion of equity attributable to a single security. For Roivant Sciences Ltd. (ROIV), this metric demonstrates asset resilience amid geopolitical risks impacting international clinical trials. Analyzing the book value per share allows for the identification of long-term trends in the holding company's asset accumulation. Growth in this indicator reduces the probability of default, although it may signal a decline in profitability. Investors should utilize this trend to assess the fundamental protection of capital.

Competitors of Roivant Sciences Ltd. (ROIV)

Book Value per Share LLY (Eli Lilly & Co.)|AbbVie Corp. (ABBV) - Net Assets per Share|AstraZeneca PLC (AZN) - Accounting Value per Share|NVS (novartis.com) - Net Assets per Single Share|Net Assets per Single Share Merck MRK|Share Book Value Novo Nordisk AS|Amgen Corporation (AMGN) - Book Value per Share|Accounting Value of a Share Pfizer Corp (PFE)|Book Value per Share SNY (Sanofi)|bms.com - Book Value per Share|Net Assets per Single Share GSK Corp (GSK)|TAK: Accounting Value of a Share|TEVA (Teva) - Net Assets per Single Share|Dr. Reddy's Labs (RDY) - Accounting Value per Share|VTRS (Viatris Inc.) - Book Value per Share|Book Value per Share zailaboratory.com (ZLAB)|Bausch Health (BHC) - Accounting Value per Share|Accounting Value of a Share Cosmos Health, Inc. (COSM)